Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Axonics, Inc. - Common Stock (NQ:AXNX)

70.98 UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Axonics, Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
Axonics Q1 Soars Past Estimates: Analysts Say Annual Sales Outlook Is 'Conservative' ↗
Axonics Inc (NASDAQ: AXNX) reported a Q1 EPS loss of $(0.19), better than the consensus of $(0.29). 
Via Benzinga
News headline image
Analyst Ratings for Axonics ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2023 ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2023 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 1, 2023 ↗
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million. 
Via Benzinga
News headline image
Axonics Modulation Tech Earnings Preview ↗
 
Via Benzinga
Analyst Ratings for Axonics ↗
 
Via Benzinga
News headline image
2 Fast-Growing Healthcare Stocks to Buy and Hold ↗
The innovative companies have made great gains in a short period of time. 
Via The Motley Fool
News headline image
Earnings Scheduled For May 1, 2023 ↗
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million. 
Via Benzinga
News headline image
Axonics Earnings Preview ↗
 
Via Benzinga
News headline image
Axonics Posts Smaller Than Expected Quarterly Loss, Raises Guidance ↗
 
Via Benzinga
News headline image
Why Axonics Shares Are Trading Higher Today? ↗
Axonics, Inc. (NASDAQ: AXNX) shares are trading higher after the company reported preliminary fourth-quarter and full-year 2022 total net revenue results above estimates. The company also issued FY23... 
Via Benzinga
News headline image
Earnings Scheduled For October 31, 2022 ↗
Companies Reporting Before The Bell • Insperity (NYSE:NSP) is estimated to report quarterly earnings at $0.96 per share on revenue of $1.46 billion. 
Via Benzinga
News headline image
Analyst Ratings for Axonics ↗
Axonics (NASDAQ:AXNX) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Axonics Risk/Reward Ratio Is Less Favorable, Analyst Says While Downgrading Stock ↗
Needham downgraded Axonics Inc (NASDAQ: AXNX) from Buy to Hold. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Where Axonics Stands With Analysts ↗
Within the last quarter, Axonics (NASDAQ:AXNX) has observed the following analyst ratings: 
Via Benzinga
News headline image
What 9 Analyst Ratings Have To Say About Axonics ↗
Within the last quarter, Axonics (NASDAQ:AXNX) has observed the following analyst ratings: 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Analyst Ratings for Axonics ↗
Within the last quarter, Axonics (NASDAQ:AXNX) has observed the following analyst ratings: 
Via Benzinga
News headline image
Leading Medical Stocks, Including Sensus And Shockwave, Have Grown At Least 36% This Year ↗
Biotech isn't the only place to make money in health care this year. 
Via Investor's Business Daily
News headline image
Piper Sandler Maintains Overweight Rating for Axonics: Here's What You Need To Know ↗
Piper Sandler has decided to maintain its Overweight rating of Axonics (NASDAQ:AXNX) and raise its price target from $82.00 to $84.00. Shares of Axonics are trading down 1.5% over the last 24 hours, at... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers Applied DNA Sciences (NASDAQ:APDN) stock rose 90.0% to $5.32 during Tuesday's after-market session. At the close, Applied DNA Sciences's trading volume reached 28.8 million shares. This is... 
Via Benzinga
News headline image
Neuromodulation Focused Company Axonics Gets 28% Price Target Bump By This Analyst On Solid Q2 Performance ↗
 
Via Benzinga
News headline image
Morgan Stanley Maintains Overweight Rating for Axonics: Here's What You Need To Know ↗
Morgan Stanley has decided to maintain its Overweight rating of Axonics (NASDAQ:AXNX) and raise its price target from $73.00 to $80.00. Shares of Axonics are trading up 5.7% over the last 24 hours, at... 
Via Benzinga
News headline image
Recap: Axonics Q2 Earnings ↗
Axonics (NASDAQ:AXNX) reported its Q2 earnings results on Monday, August 1, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Axonics beat estimated earnings by... 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Gainers Rockwell Medical (NASDAQ:RMTI) stock rose 9.2% to $0.4 during Monday's after-market session. The company's market cap stands at $37.5 million. 
Via Benzinga
News headline image
Earnings Scheduled For August 1, 2022 ↗
Companies Reporting Before The Bell • Bon Natural Life (NASDAQ:BON) is projected to report earnings for its first quarter. 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.